Pathstone Family Office, LLC Sarepta Therapeutics, Inc. Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 3,204 shares of SRPT stock, worth $385,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,204Holding current value
$385,889% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding SRPT
# of Institutions
559Shares Held
85.5MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.24 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.09 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$520 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$499 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$460 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $10.5B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...